% | ||
---|---|---|
Countries where drugs were used | ||
In home country AND in France | 72.2 | |
In home country AND only as substitution treatment in France | 4.8 | |
In France AND never in home country | 19.5 | |
Only abroad (neither in home country nor in France) | 3.5 | |
Country of first drug use | ||
Home country | 77.0 | |
France | 19.5 | |
Other | 3.5 | |
First injection | ||
Injection at least once in lifetime | ||
No | 4.5 | |
Yes | 95.5 | |
Age of first injection (avg, 21.8 years old; SD, 6.2 years, 13–40 years old) | ||
1 < 20 | 41.0 | 42.9 |
2 20–24 | 30.3 | 31.7 |
3 25–29 | 13.5 | 14.2 |
4 30+ | 10.7 | 11.2 |
N/A (never injected) | 4.5 | – |
Context of 1st injection | ||
Alone | 26.0 | 27.2 |
With assistance of third party | 69.5 | 72.8 |
N/A (never injected) | 4.5 | – |
First product injected | ||
Heroin | 41.7 | 43.6 |
Cherniashka (opioid concoction) | 16.9 | 17.7 |
Morphine | 10.3 | 10.8 |
Opium | 7.9 | 8.2 |
Buprenorphine (Subutex) | 6.3 | 6.5 |
Other: morphine sulfates (Skenan, Moscontin), desomorphine, krokodil, benzodiazepines, cocaine, tranquilizers, vint | 12.5 | 13.1 |
N/A (never injected) | 4.5 | – |
Evolution of products consumed since arrival in France | ||
Injection in the last month | ||
At least one injection in the last month | 71.1 | |
Daily injection in the last month | 50.4 | |
Weekly injection in the last month | 30.7 | |
Monthly injection in the last month | 18.9 | |
Products consumed in home country | ||
Cherniashka (opioid concoction) | 46.7 | |
Heroin | 21.3 | |
Pervitine, ephedrine, vint, jeff | 14.1 | |
Crystal meth | 9.4 | |
Desomorphine, krokodil | 5.2 | |
Buprenorphine (Subutex, Temgesic) | 3.4 | |
Opium | 2.3 | |
Cocaine | 1.6 | |
Amphetamines—speed | 1.3 | |
Codein, morphine | 2.6 | |
Other (brown sugar, pills/medication) | 0.4 | |
Products consumed in France | ||
Morphine sulfates (Skenan, Moscontin) | 54.4 | |
Methadone | 37.8 | |
Buprenorphine (Subutex, Temgesic) | 33.3 | |
Cocaine | 24.5 | |
Crack, free base | 15.0 | |
Amphetamines—speed | 2.3 | |
Heroin | 2.2 | |
Opium | 0.4 | |
Non-Adherence to harm reduction recommendations (syringe sharing) | ||
Syringe sharing in the last month | 9.3 | |
Syringe sharing since arrival in France | 13.9 | |
Syringe sharing in home country | 49.9 | |
Syringe sharing in lifetime | 62.3 |